{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:15:09Z","timestamp":1790154909486,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":25,"publisher":"Springer New York","isbn-type":[{"value":"9781493933884","type":"print"},{"value":"9781493933891","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3389-1_10","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:22:46Z","timestamp":1460632966000},"page":"153-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Towards a Preventive Strategy for Toxoplasmosis: Current Trends, Challenges, and Future Perspectives for Vaccine Development"],"prefix":"10.1007","author":[{"given":"Ragab M.","family":"Fereig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.amjmed.2004.08.023","volume":"118","author":"JD Kravetz","year":"2005","unstructured":"Kravetz JD, Federman DG (2005) Toxoplasmosis in pregnancy. Am J Med 118:212\u2013216","journal-title":"Am J Med"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30:1217\u20131258","journal-title":"Int J Parasitol"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965\u20131976","journal-title":"Lancet"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.pt.2010.01.009","volume":"4","author":"SA Elmore","year":"2010","unstructured":"Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP (2010) Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol 4:190\u2013196","journal-title":"Trends Parasitol"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1574-6976.2011.00305.x","volume":"36","author":"WJ Sullivan Jr","year":"2012","unstructured":"Sullivan WJ Jr, Jeffers V (2012) Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol Rev 36:717\u2013733","journal-title":"FEMS Microbiol Rev"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1586\/erv.09.27","volume":"6","author":"J Kur","year":"2009","unstructured":"Kur J, Holec-Gasior L, Hiszczynska-Sawicka E (2009) Current status of toxoplasmosis vaccine development. Expert Rev Vaccines 6:791\u2013808","journal-title":"Expert Rev Vaccines"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1590\/S0074-02762009000200018","volume":"104","author":"EA Innes","year":"2009","unstructured":"Innes EA, Bartley PM, Maley S, Katzer F, Buxton D (2009) Veterinary vaccines against Toxoplasma gondii. Mem Inst Oswaldo Cruz 104:246\u2013251","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1517\/13543776.2012.668886","volume":"22","author":"JB Rodriguez","year":"2012","unstructured":"Rodriguez JB, Szajnman SH (2012) New antibacterials for the treatment of toxoplasmosis; a patent review. Expert Opin Ther Pat 22:311\u2013333","journal-title":"Expert Opin Ther Pat"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1701-2163(15)31053-7","volume":"35","author":"C Paquet","year":"2013","unstructured":"Paquet C, Yudin MH (2013) Toxoplasmosis in pregnancy: prevention, screening and treatment. J Obstet Gynaecol Can 35:78\u201381","journal-title":"J Obstet Gynaecol Can"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.exppara.2007.01.017","volume":"116","author":"G Dautu","year":"2007","unstructured":"Dautu G, Munyaka B, Carmen G, Zhang G, Omata Y, Xuenan X, Igarashi M (2007) Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential. Exp Parasitol 116:273\u2013282","journal-title":"Exp Parasitol"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.vaccine.2006.10.060","volume":"25","author":"M D\u00f6\u015fkaya","year":"2007","unstructured":"D\u00f6\u015fkaya M, Kalantari-Dehaghi M, Walsh CM, Hiszczy\u0144ska-Sawicka E et al (2007) GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine. Vaccine 25:1824\u20131837","journal-title":"Vaccine"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1128\/CVI.00397-12","volume":"19","author":"PY Wang","year":"2012","unstructured":"Wang PY, Yuan ZG, Petersen E, Li J et al (2012) Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice. Clin Vaccine Immunol 19:1916\u20131920","journal-title":"Clin Vaccine Immunol"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/pim.12024","volume":"35","author":"P Gong","year":"2013","unstructured":"Gong P, Huang X, Yu Q, Li Y et al (2013) The protective effect of a DNA vaccine encoding the Toxoplasma gondii cyclophilin gene in BALB\/c mice. Parasite Immunol 35:140\u2013146","journal-title":"Parasite Immunol"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/1756-3305-7-431","volume":"7","author":"IA Hassan","year":"2014","unstructured":"Hassan IA, Wang S, Xu L, Yan R, Song X, Li X (2014) DNA vaccination with a gene encoding Toxoplasma gondii deoxyribose phosphate aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice. Parasit Vectors 7:431","journal-title":"Parasit Vectors"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1016\/j.vaccine.2007.02.057","volume":"25","author":"M Golkar","year":"2007","unstructured":"Golkar M, Shokrgozar MA, Rafati S, Musset K et al (2007) Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine 25:4301\u20134311","journal-title":"Vaccine"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.exppara.2012.01.001","volume":"130","author":"X Huang","year":"2012","unstructured":"Huang X, Li J, Zhang G, Gong P, Yang J, Zhang X (2012) Toxoplasma gondii: protective immunity against toxoplasmosis with recombinant actin depolymerizing factor protein in BALB\/c mice. Exp Parasitol 130:218\u2013222","journal-title":"Exp Parasitol"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1016\/j.vaccine.2013.07.058","volume":"31","author":"B Zheng","year":"2013","unstructured":"Zheng B, Lu S, Tong Q, Kong Q, Lou D (2013) The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine 31:4578\u20134584","journal-title":"Vaccine"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1371\/annotation\/5fa9cfb4-9964-4586-845d-d8205f318d68","volume":"8","author":"HL Wang","year":"2013","unstructured":"Wang HL, Li YQ, Yin LT, Meng XL, Guo M et al (2013) Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis. PLoS One 8:8","journal-title":"PLoS One"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00436-005-0074-y","volume":"98","author":"P Flori","year":"2006","unstructured":"Flori P, Tardy L, Jacquet A, Bellete B, Hafid J, Raberin H, Tran Manh Sung R (2006) Effect of rSAG-1(P30) immunisation on the circulating and tissue parasites in guinea pigs as determined by quantitative PCR. Parasitol Res 98:511\u2013518","journal-title":"Parasitol Res"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1756-3305-6-34","volume":"6","author":"SC Chuang","year":"2013","unstructured":"Chuang SC, Ko JC, Chen CP, Du JT, Yang CD (2013) Induction of long-lasting protective immunity against Toxoplasma gondii in BALB\/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles. Parasit Vectors 6:34","journal-title":"Parasit Vectors"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.exppara.2013.07.013","volume":"135","author":"D Qu","year":"2013","unstructured":"Qu D, Han J, Du A (2013) Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re. Exp Parasitol 135:234\u2013239","journal-title":"Exp Parasitol"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.parint.2012.04.001","volume":"61","author":"L Yu","year":"2012","unstructured":"Yu L, Yamagishi J, Zhang S, Jin C, Aboge GO, Zhang H, Zhang G, Tanaka T, Fujisaki K, Nishikawa Y, Xuan X (2012) Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice. Parasitol Int 61:481\u2013486","journal-title":"Parasitol Int"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.vaccine.2014.01.095","volume":"32","author":"S Tanaka","year":"2014","unstructured":"Tanaka S, Kuroda Y, Ihara F, Nishimura M, Hiasa J, Kojima N, Nishikawa Y (2014) Vaccination with profilin encapsulated in oligomannose-coated liposomes induces significant protective immunity against Toxoplasma gondii. Vaccine 32:1781\u20131785","journal-title":"Vaccine"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0014-5793(98)01577-4","volume":"441","author":"M Fukasawa","year":"1998","unstructured":"Fukasawa M, Shimizu Y, Shikata K, Nakata M, Sakakibara R, Yamamoto N, Hatanaka M, Mizuochi T (1998) Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes. FEBS Lett 441:353\u2013356","journal-title":"FEBS Lett"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-3024.2007.00937.x","volume":"29","author":"Y Shimizu","year":"2007","unstructured":"Shimizu Y, Takagi H, Nakayama T, Yamakami K, Tadakuma T, Yokoyama N, Kojima N (2007) Intraperitoneal immunization with oligomannose-coated liposome-entrappedsoluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB\/c mice through uptake by peritoneal macrophages. Parasite Immunol 29:229\u2013239","journal-title":"Parasite Immunol"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3389-1_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T10:04:00Z","timestamp":1608631440000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3389-1_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933884","9781493933891"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3389-1_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"14 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}